OBJECTIVE AND METHOD: To outline the direct and indirect approaches in the fight against blood doping in sports, the different strategies that have been used and are currently being used to fight efficiently against blood doping are presented and discussed. RESULTS AND CONCLUSIONS: The paper outlines the different approaches and diagnostic tools that some federations have to identify and target sports people demonstrating abnormal blood profiles. Originally blood tests were introduced for medical reasons and for limiting misuse of recombinant human erythropoietin (rHuEPO). In this way it became possible to prevent athletes with haematocrit levels well above normal, and potentially dangerous for their health, competing in sport. Today, with nearly a decade of blood testing experience, sports authorities should be familiar with some of the limitations and specially the ability of blood tests performed prior to competitions to fight efficiently against the misuse of rHuEPO, blood transfusion, and artificial haemoglobin.
OBJECTIVE AND METHOD: To outline the direct and indirect approaches in the fight against blood doping in sports, the different strategies that have been used and are currently being used to fight efficiently against blood doping are presented and discussed. RESULTS AND CONCLUSIONS: The paper outlines the different approaches and diagnostic tools that some federations have to identify and target sports people demonstrating abnormal blood profiles. Originally blood tests were introduced for medical reasons and for limiting misuse of recombinant humanerythropoietin (rHuEPO). In this way it became possible to prevent athletes with haematocrit levels well above normal, and potentially dangerous for their health, competing in sport. Today, with nearly a decade of blood testing experience, sports authorities should be familiar with some of the limitations and specially the ability of blood tests performed prior to competitions to fight efficiently against the misuse of rHuEPO, blood transfusion, and artificial haemoglobin.
Authors: I Casoni; G Ricci; E Ballarin; C Borsetto; G Grazzi; C Guglielmini; F Manfredini; G Mazzoni; M Patracchini; E De Paoli Vitali Journal: Int J Sports Med Date: 1993-08 Impact factor: 3.118
Authors: Fabian Sanchis-Gomar; Vladimir E Martinez-Bello; Mari Carmen Gomez-Cabrera; Jose Viña Journal: Eur J Appl Physiol Date: 2010-01-01 Impact factor: 3.078
Authors: F Sanchis-Gomar; V E Martinez-Bello; E Domenech; A L Nascimento; F V Pallardo; Mari Carmen Gomez-Cabrera; J Vina Journal: Eur J Appl Physiol Date: 2009-08-08 Impact factor: 3.078
Authors: Robert Gajda; Aleksandra Samełko; Miłosz Czuba; Agnieszka Piotrowska-Nowak; Katarzyna Tońska; Cezary Żekanowski; Anna Klisiewicz; Wojciech Drygas; Anita Gębska-Kuczerowska; Jacek Gajda; Beat Knechtle; Jakub Grzegorz Adamczyk Journal: Int J Environ Res Public Health Date: 2021-03-01 Impact factor: 3.390